Skip to content
AIO Attend.

Hotel Palace Berlin · 10 and 11 February 2027

The gap is not adoption.It is the plant.

Who governs.  ·  Who decides.  ·  Who is accountable.

The gap · Manufacturing

AI is inthe plant.
The chain needs an owner.

Accenture's February 2026 study traces 64% of drug launch delays to chemistry, manufacturing and controls, and finds only 35% of manufacturing leaders run a connected operation. Lilly and Roche now model their production lines as digital twins, and MSD is taking agentic AI into manufacturing with Google Cloud. The question in Berlin is who owns the plant data that closes the gap.

The batch record still carries a person's signature. The data behind it now runs through models, twins and platforms. The leaders who sign are the ones who decide which of those the plant relies on.

AI deploys when the chain has an owner. In Berlin, the owner signs at the plant.

The imperative · three premises

01
The accountability is missing.

Digital twins now test a process before capital is committed, and automation compresses the path from batch to release. The plants that scale AI are the ones whose data is connected end to end, with one owner for it.

02
The regulatory frontier is moving.

Regulators on both sides of the Atlantic expect the quality unit to clear what a model drafts. The organisations that build the validation, data provenance and ownership layer now set the standard others will follow.

03
The data layer sets the ceiling.

Every AI prediction in the plant is only as good as the data beneath it. Connected PAT streams, structured batch records and one data owner turn a pilot into a platform.

The Conversation · AIO Circle Berlin 2027

Up to 30 leaders.Curated. Invite only.

The AI Strategy discussion sits on Day Two at 11:00 in BILS, CGTI and MEVO: thirty minutes, one question, with the leaders who run the plant and choose what it runs on. No conference floor. No vendor showcase.

Hotel Palace Berlin, 11 February 2027. The manufacturing conversation sits inside BILS, CGTI and MEVO, where biologics, cell and gene therapy and fermentation leaders meet.

30
Curated leaders · not by application
90
Minutes · two talks · one panel · no schedule overhead
70%+
In leadership · principals only
Hotel Palace Berlin · Budapester Strasse 45 · 10787
10 and 11 February 2027
Next conversation scheduled
Hotel Palace Berlin · February 2027
View the Conversations →

Previous voices · Manufacturing & Bioprocess

Who has held it.

2026 faculty.

PP
Philip Probert
Director, Biologics & RNA · Centre of Excellence
CPI
BILS/AIO 2026
AD
Andreia Duarte
EMEA Commercial Director
GenScript
BILS/AIO 2026
JZ
Jesus Zurdo
Director
ARA Biosciences
BILS/AIO 2026
UG
Uwe Gottschalk
Operating Partner · Co-Chair
Keensight Capital · Former CSO, Lonza
DDIF 2026 · BILS/AIO 2026
HP
Dr Harsukh Parmar
Former SVP, Global Head R&ED
EMD Serono / Merck KGaA
DDIF 2026 · BILS/AIO 2026

2027 faculty announced in cadence with the programme.  View voices →

AIO Circle · Berlin 2027

The manufacturingconversation.

Attend → View the Conversations →

By nomination · by direct introduction.